Buprenorphine Tablet
Product Images NDC 58118-4459

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 58118-4459). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine-figure (Buprenorphine Figure)

An instructional illustration showing a person placing a sublingual tablet under their tongue. The image focuses on the open mouth with the tongue slightly raised, demonstrating the correct administration method for a sublingual tablet.*

FDA Label Image

Close-up Of A Labelai-generated Content May Be Incorrect. (Buprenorphine Label 2mg)

Packaging label for Buprenorphine SL 2 mg sublingual tablets from Clinical Solutions Wholesale. The label includes the NDC 58118-4459-8, quantity of 30 tablets, and manufacturer information: Sun Pharmaceutical Industries, Cranbury, NJ. Additional identifiers include GTIN, batch number SAMPLE163, and expiration date February 2026.*

FDA Label Image

Buprenorphine-str (Buprenorphine Str)

Chemical structure of Buprenorphine hydrochloride, showing its molecular arrangement with rings, hydroxyl groups, and side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.